Technical data

Global Advanced Image Processing and Processing Planning Systems Market (2021-2028) Size, Share and Trend Analysis Report


DUBLIN, October 07, 2021– (BUSINESS WIRE) – The “Global Treatment Planning and Advanced Image Processing Systems Market Size, Share and Trend Analysis Report by Component, by Technique, by Application (Adaptive Radiation Therapy) , dose accumulation), by region and segment forecast, 2021 The -2028 report “has been added to offer.

The global advanced image processing and processing planning systems market size is expected to reach $ 3.0 billion by 2028. The market is expected to grow at a CAGR of 7.8% from 2021 to 2028.

The increasing prevalence of cancer and the increasing development of cancer research related products undertaken by key players are driving the growth of the market. According to estimates published by GLOBOCAN in 2020, 19.3 million new cancer cases have been diagnosed and 10.0 million cancer-related deaths recorded.

According to the WHO, cancer is the leading cause of death worldwide and kills one in six. According to Novartis, there are over 200 types of cancer prevalent in the world and each requires a unique diagnosis and line of treatment. The increasing burden of cancer is expected to drive the demand for advanced oncology therapies with precise and effective results, thereby contributing to the growth of the market.

In addition, the field of oncology is witnessing innovations and investments from market leaders to develop new technologies that have the potential to radically change the treatment regimen. Advances in healthcare infrastructure and eroding opportunities in emerging markets are contributing to growth. Governments around the world are encouraging public-private collaboration to accelerate product development.

Recent developments in the field of imaging technology have found wide-scale adoption in treatment planning, treatment simulation, and image guidance in radiation therapy processes. For example, in January 2021, OncoLens raised $ 7.3 million in a Series A funding round. In addition, General Atlantic invested approximately $ 200.0 million to launch OneOncology, a company designed to help community practices in oncology with technical data, innovation and research. In addition, Purdue Pharma LP is investing in its R&D in oncology to diversify scientific research into areas of unmet medical need and thereby establish a potential portfolio of delivering new cancer therapies to patients over the next several years.

Additionally, artificial intelligence (AI) and machine learning (ML) are seeing increasing adoption in oncology software systems to improve diagnosis, treatment planning, simulation and management. The AI ​​/ ML merger has dramatically improved the diagnostic and imaging segments of cancer care. One of the strengths of these deep learning algorithms has been the detection of skin cancer from photographs of the skin.

AI used in cancer screening and detection further facilitates treatment planning processes and prevents collateral damage to tissues / organs. For example, the American College of Radiology founded the Data Science Institute to promote collaboration between radiologists, private and public agencies to adopt and develop AI-based imaging solutions. Likewise, the American Society of Clinical Oncology and the American Society for Radiation Oncology launched CancerLinQ and the National Institute of Health founded the Big Data to Knowledge initiative. In addition, increased investment in AI for oncology contributes to the development and growth of the market.

Highlights of the Treatment Planning Systems and Advanced Image Processing report

  • The market is expected to witness significant growth during the forecast period owing to the increasing prevalence of cancer and increasing investment in oncology.

  • Treatment planning software dominated the segment of treatment planning systems and advanced image processing components in 2020, due to increased demand for precise and precise processing options.

  • Image recording application validation dominated the market in 2020 due to a growing need to train real-time image datasets from multimodality and anatomical atlases

  • North America dominated the market in 2020 due to the presence of sophisticated healthcare infrastructure and cancer research institutes coupled with high healthcare spending

Market dynamics


  • Increased prevalence of cancer

  • Increase investments and strategic initiatives in radiology and oncology

  • Growing number of radiation therapy centers and hospitals adopting state-of-the-art radiation therapy machines and software

  • Growing adoption of AI / ml in oncology software




Companies mentioned

  • Accuray Incorporated

  • Elekta AB

  • MIM Software, Inc.

  • ViewRay Technologies, Inc.

  • DOSIsoft SA.

  • Prowess, Inc.

  • Brainlab

  • Varian Medical Systems, Inc.

  • RaySearch Laboratories

  • Koninklijke PHILIPS NV

For more information on this report, visit

See the source version on

Laura Wood, Senior Press Director
[email protected]
For EST office hours, call 1-917-300-0470
For USA / CAN call toll free 1-800-526-8630
For GMT office hours, call + 353-1-416-8900


Leave a Reply

Your email address will not be published.